Women Leaders in Market Access: Clare Marley, GSK on the evolution of the market access function

Om avsnittet

In this episode, Louise is joined by Clare Marley, Disease Area Head Immunology, Global Payer Strategy at GSK. Clare has been at GSK for nearly a decade where she's focused heavily on global market access and payer strategy.

As we hear in this episode, Clare has spent much of her career in market access and has seen the function evolve from an entirely new area to what it is today. She discusses the changes she's seen and shares her views on what's on the horizon for global market access teams as the function continues to evolve.

Send us Fan Mail

Om avsnittet

Fler avsnitt

Understanding Payer Perceptions with Megan O'Brien

Pricing Under Pressure: What MFN Really Means for Global Strategy

Navigating Global Policy Shifts with Nikhil Taxak

Beyond the Headlines: Understanding MFN's True Impact on Market Access

Revolutionary Strategies in Orphan Drug Development with Isabel Rubio

Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi

Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene

The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL

Authentic leadership in Market Access with Katrin Jack, Galderma

Market Access in emerging markets with Ezgi Erdogan, GSK